Development of a smartphone screening test for preclinical Alzheimer’s disease and validation across the dementia continuum

Abstract Background Dementia prevalence is predicted to triple to 152 million globally by 2050. Alzheimer’s disease (AD) constitutes 70% of cases. There is an urgent need to identify individuals with preclinical AD, a 10–20-year period of progressive brain pathology without noticeable cognitive symp...

Descripció completa

Dades bibliogràfiques

Autors principals:	Jane Alty, Lynette R. Goldberg, Eddy Roccati, Katherine Lawler, Quan Bai, Guan Huang, Aidan D Bindoff, Renjie Li, Xinyi Wang, Rebecca J. St George, Kaylee Rudd, Larissa Bartlett, Jessica M. Collins, Mimieveshiofuo Aiyede, Nadeeshani Fernando, Anju Bhagwat, Julia Giffard, Katharine Salmon, Scott McDonald, Anna E. King, James C. Vickers
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2024-04-01
Col·lecció:	BMC Neurology
Matèries:	Alzheimer’s disease Dementia TapTalk Finger-tapping Diadochokinesis Computer vision
Accés en línia:	https://doi.org/10.1186/s12883-024-03609-z
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!